204 related articles for article (PubMed ID: 26919100)
21. In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models.
Bouvet M; Hoffman RM
Methods Mol Biol; 2012; 872():51-67. PubMed ID: 22700403
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.
Sugyo A; Tsuji AB; Sudo H; Okada M; Koizumi M; Satoh H; Kurosawa G; Kurosawa Y; Saga T
PLoS One; 2015; 10(4):e0123761. PubMed ID: 25893775
[TBL] [Abstract][Full Text] [Related]
23. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis.
Subramani R; Lopez-Valdez R; Arumugam A; Nandy S; Boopalan T; Lakshmanaswamy R
PLoS One; 2014; 9(5):e97016. PubMed ID: 24809702
[TBL] [Abstract][Full Text] [Related]
24. An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models.
Metildi CA; Kaushal S; Lee C; Hardamon CR; Snyder CS; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
J Am Coll Surg; 2012 Jun; 214(6):997-1007.e2. PubMed ID: 22542065
[TBL] [Abstract][Full Text] [Related]
25. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer.
Xu JW; Wang TX; You L; Zheng LF; Shu H; Zhang TP; Zhao YP
PLoS One; 2014; 9(3):e92847. PubMed ID: 24667580
[TBL] [Abstract][Full Text] [Related]
27. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
[TBL] [Abstract][Full Text] [Related]
28. The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')₂-R1507 fragments in Ewing sarcomas.
Fleuren ED; Versleijen-Jonkers YM; Heskamp S; Roeffen MH; Bouwman WH; Molkenboer-Kuenen JD; van Laarhoven HW; Oyen WJ; Boerman OC; van der Graaf WT
Eur J Cancer; 2013 Sep; 49(13):2851-8. PubMed ID: 23664098
[TBL] [Abstract][Full Text] [Related]
29. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
[TBL] [Abstract][Full Text] [Related]
30. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
31. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
[TBL] [Abstract][Full Text] [Related]
32. Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer.
Tran Cao HS; Kaushal S; Metildi CA; Menen RS; Lee C; Snyder CS; Messer K; Pu M; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
Hepatogastroenterology; 2012 Sep; 59(118):1994-9. PubMed ID: 22369743
[TBL] [Abstract][Full Text] [Related]
33. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
[TBL] [Abstract][Full Text] [Related]
34. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.
Bouvet M; Wang J; Nardin SR; Nassirpour R; Yang M; Baranov E; Jiang P; Moossa AR; Hoffman RM
Cancer Res; 2002 Mar; 62(5):1534-40. PubMed ID: 11888932
[TBL] [Abstract][Full Text] [Related]
35. Generation of a monoclonal antibody against the extracellular domain of IGF-1R.
Nakadate Y; Yoshimura S; Nakatani N; Azuma M; Tachibana T
Monoclon Antib Immunodiagn Immunother; 2014 Apr; 33(2):126-8. PubMed ID: 24746154
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
[TBL] [Abstract][Full Text] [Related]
37. Production and characterization of monoclonal antibodies against insulin-like growth factor type 1 receptor.
Keyhanfar M; Forbes BE; Cosgrove LJ; Wallace JC; Booker GW
Hybridoma (Larchmt); 2006 Aug; 25(4):230-7. PubMed ID: 16934020
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.
Cohen BD; Baker DA; Soderstrom C; Tkalcevic G; Rossi AM; Miller PE; Tengowski MW; Wang F; Gualberto A; Beebe JS; Moyer JD
Clin Cancer Res; 2005 Mar; 11(5):2063-73. PubMed ID: 15756033
[TBL] [Abstract][Full Text] [Related]
39. Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models.
Bouvet M; Yang M; Nardin S; Wang X; Jiang P; Baranov E; Moossa AR; Hoffman RM
Clin Exp Metastasis; 2000; 18(3):213-8. PubMed ID: 11315094
[TBL] [Abstract][Full Text] [Related]
40. The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).
Cornelissen B; McLarty K; Kersemans V; Reilly RM
Nucl Med Biol; 2008 Aug; 35(6):645-53. PubMed ID: 18678349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
